While subjective, this observation aligns with the peptides known mechanisms and provides a tangible indicator that something is happening at the tissue level
Standard protocols for foot-related tendon issues typically involve 0.25-0.5 mg daily via subcutaneous injection near the affected area for 4-8 weeks
These symptoms typically resolve within 24 hours.* Not for Everyone: This therapy is not recommended for individuals allergic to cobalamin (B12), those with liver disease, or those currently taking medications that interact with methyl donors
Evidence suggests their presence indicates a distinct condition, or at least a more-clearly delineated subtype of IC/BPS
They did not constitute FDA approval, immediately place either substance on the final 503A Bulks List, or authorize universal pharmacy compounding or dispensing
This mirrors general weight loss patterns and relates to differences in lean mass, metabolic rate, and hormonal environment